Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Autor principal: | Tamanna, Mst. Taskia |
---|---|
Otros Autores: | Sharmin, Dr. Sabrina |
Formato: | Tesis |
Lenguaje: | English |
Publicado: |
Brac University
2023
|
Materias: | |
Acceso en línea: | http://hdl.handle.net/10361/18146 |
Ejemplares similares
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
por: Hassan, Md. Muhtaz
Publicado: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
por: Islam, Md. Irfath
Publicado: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
por: Alim, Abdul
Publicado: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
por: Parveen, Sanjana
Publicado: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
por: Tabassum, Nadira
Publicado: (2024)